Alnylam Pharmaceuticals Inc Price Chart
Alnylam Pharmaceuticals Inc DUL.BE Financial and Trading Overview
| Alnylam Pharmaceuticals Inc stock price | 140.4 EUR |
| Previous Close | 184.4 EUR |
| Open | 184.6 EUR |
| Bid | 183 EUR x N/A |
| Ask | 186.6 EUR x N/A |
| Day's Range | 184.6 - 184.8 EUR |
| 52 Week Range | 128.56 - 230.45 EUR |
| Volume | 45 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DUL.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alnylam Pharmaceuticals Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 230.45 EUR |
| 52 Week Low | 128.56 EUR |
| 50-Day Moving Average | 182.02 EUR |
| 200-Day Moving Average | 199.13 EUR |
DUL.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Alnylam Pharmaceuticals Inc Stock
What is a current DUL.BE stock price?
Alnylam Pharmaceuticals Inc DUL.BE stock price today per share is 140.4 EUR.
How to purchase Alnylam Pharmaceuticals Inc stock?
You can buy DUL.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alnylam Pharmaceuticals Inc?
The stock symbol or ticker of Alnylam Pharmaceuticals Inc is DUL.BE.
How many shares does Alnylam Pharmaceuticals Inc have in circulation?
The max supply of Alnylam Pharmaceuticals Inc shares is 0.
What is Alnylam Pharmaceuticals Inc Price to Earnings Ratio (PE Ratio)?
Alnylam Pharmaceuticals Inc PE Ratio is now.
What was Alnylam Pharmaceuticals Inc earnings per share over the trailing 12 months (TTM)?
Alnylam Pharmaceuticals Inc EPS is 0 EUR over the trailing 12 months.